What's Happening in Neurotech Right Now, and Why You Should Be Paying Attention
In 2026, we still understand more about the moon than we do about what's between our ears. Neurotech sits as one of venture's largest under-evaluated categories, and the technical fluency needed to underwrite it lives outside most generalist funds.
In 60 minutes, Varun Turlapati of Chaanakya Capital walks us through what's actually investable in neurotech right now, why he believes 2026 neurotech parallels 2016 AI, and how he built a focused $2M nano fund deploying into a category most generalists can't underwrite.
Who should attend
Emerging managers building thesis-led funds. Generalist GPs curious about neurotech. Aspiring fund managers exploring specialist theses. Anyone who's ever passed on a science-heavy deal because the diligence felt out of reach.
About the speaker
Varun Turlapati is founder and Managing Partner of Chaanakya Capital, a pre-seed fund investing in US neurotech and neuro-focused medtech device startups. 16 years of software engineering, a Masters in Electrical and Computer Engineering, and a VC Lab alum: the technical edge is the fund's thesis.
About the host
Myrto Lalacos is the founder of The Emerging VC, an independent platform for the next generation of fund managers. After years inside VC and helping launch more than 1,900 emerging GPs at VC Lab, Myrto now writes, hosts, and convenes the conversations that shape how the new generation of fund managers and VC leaders think and build.